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Photo-unstable chemicals sometimes behave as photo-
toxins in skin, inducing untoward clinical side-e¡ects
when exposed to sunlight. Some drugs, such as psora-
lens or £uoroquinolones, can damage genomic DNA,
thus increasing the risk of photocarcinogenesis. Here,
lome£oxacin, an antibiotic from the £uoroquinolone
family known to be involved in skin tumor develop-
ment in photoexposed mice, was studied using normal
human skin cells in culture: ¢broblasts, keratinocytes,
and Caucasian melanocytes. When treated cells were
exposed to simulated solar ultraviolet A (320^400 nm),
lome£oxacin induced damage such as strand breaks
and pyrimidine dimers in genomic DNA. Lome£oxa-
cin also triggered various stress responses: heme-oxyge-
nase-1 expression in ¢broblasts, changes in p53 status as
shown by the accumulation of p53 and p21 proteins or
the induction ofMDM2 and GADD45 genes, and stimu-
lation of melanogenesis by increasing the tyrosinase ac-
tivity in melanocytes. Lome£oxacin could also lead to
apoptosis in keratinocytes exposed to ultraviolet A: cas-
pase-3 was activated and FAS-L gene was induced.
Moreover, keratinocytes were shown to be the most
sensitive cell type to lome£oxacin phototoxic e¡ects, in
spite of the well-established e¡ectiveness of their antiox-
idant equipment. These data show that the phototoxi-
city of a given drug can be driven by di¡erent
mechanisms and that its biologic impact varies accord-
ing to cell type. Key words: DNA damage/£uoroquinolone/
melanogenesis/p53/phototoxicity/skin cells. J Invest Dermatol
121:596 ^606, 2003
C
utaneous photosensitivity reactions are of increasing
concern in dermatology. Such problems are more
and more frequent as today’s lifestyle is often asso-
ciated with exposure to sunlight. Photoreactive che-
micals or drugs sometimes trigger skin reactions
under exposure to normally harmless doses of sunlight. For ex-
ample, antibiotics, psoralens, nonsteroidal anti-in£ammatory
drugs, and tranquilizers have been described as inducing such un-
wanted side-e¡ects (Allen, 1993; Elmets, 1993). The activating
wavelengths are most often in the ultraviolet A (UVA) range
(320^400 nm). Chemical mechanisms of photosensitizing e¡ects
have been well described (see Kochevar, 1995, for a review).
Although clinical reactions associated with phototoxicity are rela-
tively well characterized (exaggerated sunburn, presence of vesi-
cles, hyperpigmentation, eczema), the corresponding mechanisms
need to be further investigated at cellular and molecular levels.
According to the literature, a great variety of lesions can give
rise to photogenotoxicity. First, adducts to DNA can be formed
by a direct interaction between the photosensitizer and DNA.
The best reported examples are furocoumarins (see Averbeck,
1994, for a review).When the energy of its excited state is close
to that of thymine, the photosensitizer can transfer the absorbed
photonic energy to DNA. If the thymine reaches its triplet
excited state, it can form a covalent link with an adjacent pyrimi-
dine: a pyrimidine dimer is then produced, even at wavelengths
where this damage is less likely to occur. Such a process was re-
ported for pyrido-psoralen in the range of solar wavelengths
(Andreu Guillo et al, 1996). But the most frequent process, or at
least the most commonly reported, is the photosensitization via
oxidative reactions. In this case, the sensitizer, once in its excited
state, reacts with oxygen and generates reactive oxygen species
(ROS) such as singlet oxygen 1O2, superoxide anion (O2
 ^), and
hydroxy radical (OH  ). As a consequence, a photosensitizer can
generate a relatively intense local oxidative stress producing a
large variety of DNA damage. Many phototoxic drugs have been
shown to induce single strand breaks in DNA; some psoralen
structures (Sage et al, 1989; Oroskar et al, 1993), antibiotics (Marti-
nez and Chignell, 1998), anti-in£ammatory drugs (Artuso et al,
1991; Agapakis-Causse et al, 2000), and porphyrins (Kochevar
and Dunn, 1990) for instance were reported to nick DNA under
light exposure.Various types of oxidative damage to purines and
pyrimidines are also commonly induced upon photooxidative
stress, depending on the nature of the ROS involved (Cadet
et al, 1997, for a review).
In this work, we have studied the e¡ects of the phototoxic
antibiotic £uoroquinolone lome£oxacin on cultured human skin
cells upon UVA exposure. Photochemical studies have shown
that, when exposed to UVA, lome£oxacin could generate ROS
(Martinez et al, 1998) as well as £uoride and reactive carbene after
photolysis (Martinez et al, 1997). Lome£oxacin was previously re-
ported to induce breaks and oxidative damage to DNA (Chetelat
et al, 1996; Reavy et al, 1997; Marrot et al, 2001; Sauvaigo et al, 2001)
and, more recently, to photosensitize pyrimidine dimers (Traynor
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and Gibbs, 1999; Sauvaigo et al, 2001). Its ability to damage lipids
was also described (Condorelli et al, 1996) and, ¢nally, its role as a
photocarcinogenic compound was questioned (Klecak et al, 1997).
Here, we have characterized some of the biologic e¡ects resulting
from lome£oxacin-induced photogenotoxic stress. Using cul-
tured human ¢broblasts, keratinocytes, and melanocytes, we ¢rst
con¢rmed the ability of lome£oxacin to induce DNA damage
such as strand breaks and pyrimidine dimers. Furthermore, we
have shown that the stress gene heme-oxygenase-1 (HO-1) was
induced. The activation of the p53 pathway was also demon-
strated either by the accumulation of the protein p53 or by its
ability to trans-activate some of its target genes such as P21,
GADD45, and MDM2. Lome£oxacin could also stimulate mela-
nogenesis under UVA exposure as shown by the increase of tyr-
osinase activity in normal human melanocytes. Finally, in human
keratinocytes, lome£oxacin could trigger apoptosis. Interestingly,
clear di¡erences in responses were observed according to cell
type. Keratinocytes were the most sensitive whereas melanocytes
seemed to be naturally protected by their endogenous melanin.
MATERIALS AND METHODS
Chemicals Culture media for human cells were from Clonetics
(Walkersville, MD). Phosphate-bu¡ered saline (PBS) was from Gibco-
BRL (New York, NY). The £uoroquinolone lome£oxacin was from
Sigma (St Louis, MO).
Monoclonal antibodies directed against cyclobutane thymine dimers
were obtained from TNO (Leiden, The Netherlands). Agarose for the
comet assay was the low melting Incert Agarose from FMC (Rockland,
MA). Excell gels sodium dodecyl sulfate (SDS) from Amersham
(Amersham, Buckinghamshire, UK) were used for SDS polyacrylamide
gel electrophoresis (PAGE). Nitrocellulose membranes and polyvinylidene
£uoride membranes (Hybond, Amersham) were used for protein or DNA
transfer, respectively.
Biologic systems Normal human ¢broblasts, keratinocytes, and
Caucasian melanocytes were neonatal cells from Clonetics or Cascade
(Portland, OR). Fibroblasts and keratinocytes were cultured as generally
reported (Boyce and Ham, 1983). Melanocytes were cultured in conditions
where they can respond to a-melanocyte-stimulating hormone and UV
irradiation as described by Im et al (1998). When necessary, the number
of viable cells was assessed by the 3-[4, 5-dimethylthiazol-2-yl]-2, 5
diphenyltetrazolium bromide (MTT) assay as described by the supplier
(Roche, Mannheim, Germany) or by cell counting (for tyrosinase activity
analysis for instance) using a cell counter (Beckman Coulter, Fullerton,
CA).
Light sources and spectral measurement The light source was a solar
UV simulator from Oriel (Stratford, CT) equipped with a 1000 W xenon
short arc lamp, a dichroic mirror, and an appropriate cut-o¡ ¢lter for UVA
(WG335/3 mm cut-o¡ ¢lter). The beam size was 152152 mm. The
incident UV spectrum was analyzed with a spectroradiometer (Instaspec
IV, Oriel). Such a spectral power distribution was relatively close to that of
UVA in sunlight. Our experiments were thus performed in realistic
conditions of irradiation. The average irradiance was measured by
integrating the area under the spectrum. Spectroradiometry gave the
following £uences: 9 W per m2 for UVA2 (320^340 nm) and 68.5 W per
m2 for UVA1 (340^400 nm). Thus exposures of 15 min or 30 min
correspond to doses of 70 kJ per m2 or 140 kJ per m2, respectively.
Irradiation procedure Cells were incubated for 30 min with
lome£oxacin in the dark and then exposed to UVA in the presence of
lome£oxacin in PBS. When exposure was followed by post treatment
incubation, cells were rinsed and covered again with the initial growth
medium without lome£oxacin. When the comet assay was performed
immediately after exposure, cells were ¢rst embedded in an agarosePBS
microgel and irradiated in cold PBS (41C) in the presence of
lome£oxacin.
Experiments were performed at least twice for each cell type.
Comet assay The comet assay was performed as described by Alapetite
et al (1996). Immediately after irradiation, the 0.5% agarose slide with
embedded cells was placed into the lysis bu¡er (NaCI 2.5 M;
ethylenediamine tetraacetic acid (EDTA) 100 mM; Triton X-100 1%; Tris
10 mM pH 10) for 1 h 30 min at 41C and then washed and equilibrated in
alkaline bu¡er (0.3 M NaOH, 1 mM EDTA). The electrophoresis was
performed for 20 min at 25 V and 300 mA in the same bu¡er in the
presence of 1% dimethyl sulfoxide. After neutralization in Tris bu¡er (pH
7.5), DNA was stained with ethidium bromide (2 mg per ml) and the
comets were examined and photographed with a £uorescence microscope.
For the quanti¢cation, a mean tail moment for 50 analyzed nuclei was
calculated using software image analysis (Comet 4.0, Kinetic Imaging,
Silver Spring, CO).
Semiquantitative RT-PCR The RNeasy mini kit (Qiagen, Hilden,
Germany) was used to produce preparations of total RNA from skin cells
as described by the supplier.
First strand cDNA synthesis and PCR were performed using a
RoboCycler Gradient 96 Temperature Cycler with Hot Top Assembly
(Stratagene, La Jolla, CA). First strand cDNA was synthesized using 5 mg
of total RNA as template by extension of 300 ng oligo-dT and the ¢nal
concentrations of reagents in a 50 mL reaction volume as described by the
supplier (ProSTAR First Strand RT-PCR kit, Stratagene). Speci¢c primers
to amplify the GAPDH, MDM2, GADD45, and HO-1 genes were from
Genset (Evry, France) and FAS-L gene from R&D Systems (Minneapolis,
MN). PCR thermocycling conditions for gene expression were set up as
follows: 1 cycle of activation at 951C for 15 min; followed by 25^35 cycles
at 941C for 30 s, 25^35 cycles at 55^621C for 30 s, and 25^35 cycles at
721C for 1 min; followed by a ¢nal primer sequence extension at 721C for
10 min.
The sense and antisense primer sequences used were the following
(annealing temperature in parentheses): GAPDH, 50 -CCACCCATGGCA-
AATTCCATGGCA-30 and 50 -TCTAGACGGCAGGTCAGGTCCACC-30
(601C); MDM2, 50 -GGCAGGGGAGAGTGATACAG-30 and 50 -GTCTA-
CATACTGGGCAGGGC-30 (581C); GADD45, 50 -GGAAGTGTCCAGC-
AAAGCCC-30 and 50 -GTCATCTATCTCCGGGCCCC-30 (581C); HO-1,
50 -CCGCAACCCGACAGCATGCC-30 and 50 -GCCGCTTCACATAG-
CGCTGC-30 (621C). FAS-L (human FasL Primer Pair, from R&D
Systems) was ampli¢ed using 2 units of Faststart Taq DNA polymerase
with an activation at 951C for 4 min. PCR samples (10 mL) were analyzed
on an ethidium-bromide-stained 1% agarose gel. The relative amounts
of RT-PCR products were quanti¢ed using a bioimaging system
Chemigenius (Syngene, Cambridge, UK). In order to rigorously evaluate
the modulation of gene expression, we controlled that GAPDH expression
remained unchanged in ¢broblasts and in keratinocytes exposed to UVA in
the presence of lome£oxacin (data not shown). As a practical consequence,
in all experiments dealing with gene induction presented below,
quanti¢cation of RT-PCR products was systematically standardized using
GAPDH expression level measured simultaneously.
Quantitative assessment of thymine dimers Immediately after
exposure to UVA and lome£oxacin, DNA was prepared as previously
described (Eveno et al, 1995). Puri¢ed DNA was then loaded on a
polyvinylidene £uoride membrane (Hybond-P, Amersham) and subjected
to immuno-detection of thymine dimers using monoclonal antibodies as
reported elsewhere (Otto et al, 1999). Quanti¢cation was obtained
by scanning the blots on a Fluor-Imager (Molecular Dynamics,
Sunnyvale, CA).
Preparation of nuclear extracts and western blot analysis of p53 and
p21 proteins At 24 h post exposure, cells were harvested and proteins of
the nucleus were extracted according to the method of Lin and Benchimol
(1995). Equal amounts of proteins were separated by SDS-PAGE and
transferred onto a nitrocellulose membrane. Western blot analysis was
carried out according to Super-Signal Westpico western blot system
instructions (Pierce, Rockford, IL) using the anti-p53 antibody clone
OP43 or anti-waf1 clone OP64 (Oncogene, Boston, MA).
Assessment of caspase-3 activation Caspase-3 activation was assessed
using the CaspACE colorimetric assay (Promega, Madison, WI) as
described by the supplier. This test is based on the ability of activated
caspase-3 to cleave the peptide Asp-Glu-Val-Asp labeled with
p-nitroaniline and to release this chromophore.
Tyrosinase activity Tyrosinase activity was assayed spectrophotometrically
by following the oxidation of L-dihydroxyphenylalanine (L-DOPA) to
dopachrome at 475 nm (Takahashi and Parsons, 1992). Cells were washed
with PBS and lyzed with 200 mL of 1% Triton-X100/PBS. After sonication
and vibration, 150 mL of 5 mM L-DOPAwas added to 50 mL lysis bu¡er (or
boiled cell lysate). The absorbance values were compared with a standard
curve obtained with mushroom tyrosinase (Sigma). The standard curve was
linear within the range of experimental values, and there was no increase in
absorbency in the control wells.
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RESULTS
Photocytotoxicity and photogenotoxicity of lome£oxacin
under UVA exposure Cells (¢broblasts, keratinocytes, or
melanocytes) were exposed to UVA for 30 min in the presence
of increasing lome£oxacin concentrations. Photocytotoxicity
was measured 24 h post treatment using the MTTassay. Figure 1
shows that lome£oxacin plus UVA treatment produced a dose-
dependent phototoxic e¡ect in keratinocytes, whereas ¢broblasts
and melanocytes were either slightly a¡ected or not a¡ected at
all. At low concentrations (1 mM or 5 mM) keratinocytes did not
grow, whereas at 10 mM they were killed and some cells started to
detach 24 h post treatment. Photocytotoxicity could also be
observed with ¢broblasts and melanocytes but at higher
concentrations (over 25 mM), melanocytes being the most
resistant cell type (data not shown).
Photoinduction of DNA damage by lome£oxacin was ¢rst
studied using the comet assay, a simple and visual as well
as quantitative technique for measuring DNA breakage in
the nuclei of individual cells (Tice et al, 2000). Necrosis and
apoptosis can induce nonspeci¢c DNA breakage, however, and
must be avoided when the comet assay is carried out. Moreover,
UVA radiation was also reported to induce breaks in genomic
DNA (Alapetite et al, 1996; Marrot et al, 1999). Thus, in order to
lower UVA-induced DNA breakage and to prevent cell death,
exposure time was limited to 15 min in comet assays performed
here. In such conditions, we controlled that cell integrity was not
a¡ected when the comet assay was carried out (immediately after
UVA exposure) using the two dyes carboxy-£uorescein diacetate
and ethidium bromide as previously described (Strauss, 1991)
(data not shown).
Figure 2(a) shows the typical aspects of comets for each cell
type (¢broblasts, keratinocytes, and melanocytes) after treatment
with 20 mM lome£oxacin and a 15 min UVA exposure. In Fig
2(b), mean tail moments (based on the comet tail length and
its £uorescence intensity) were calculated for increasing
lome£oxacin concentrations. A dose-dependent induction of
DNA breakage was observed, and here again keratinocytes were
the most sensitive cell type. In contrast, melanocytes were less
a¡ected under these experimental conditions.
Photoproduction of cyclobutane pyrimidine dimers (CPD) by
lome£oxacin exposed to UVA was previously reported in
cultured cells using the comet assay after T4 endonuclease V
digestion (Traynor and Gibbs, 1999). T4 endonuclease V can also
cleave DNA at abasic sites, however, and we preferred to use here
a more speci¢c assay based on immunochemical detection of
CPD. As our goal was to check whether lome£oxacin could
actually produce CPD within genomic DNA of cells, we treated
¢broblasts and keratinocytes with relatively high lome£oxacin
concentrations (50 mM and 100 mM) without considering
photocytotoxicity. DNA was extracted immediately after UVA
exposure and CPD were assessed using dot-blot analysis. Figure 3
shows that CPD were formed after treatment by lome£oxacin
plus UVA exposure in both keratinocytes and ¢broblasts,
keratinocytes being clearly more susceptible. Indeed, 3- to 4-
fold more CPD were induced in keratinocytes than in
¢broblasts. At present, there is no obvious explanation for such a
di¡erence between ¢broblasts and keratinocytes. It is worth
noting, however, that keratinocytes were also more sensitive
than ¢broblasts to CPD induction by UVA alone in our
experimental conditions.
The next series of experiments focused on speci¢c cell
responses. Here our goal was now to mimic realistic
phototoxicologic conditions likely to be encountered in human
skin and to study the e¡ects of subphototoxic exposures,
checking for a possible threshold level above which a speci¢c
stress response could be induced.
This is why lower amounts of lome£oxacin were used (up to a
maximum of 10 mM) but with longer UVA exposure (30 min)
knowing that the UVA £uence from our solar simulator was
close to that of sunlight.
Lome£oxacin plus UVA treatment induced the stress gene
HO-1 Lome£oxacin was reported to induce oxidative damage
probably due to ROS production during UVA exposure. It was
thus expected that it might trigger responses commonly related
to oxidative stress. This was demonstrated here by showing the
induction of HO-1 gene up to a maximum of 5- fold versus
unirradiated background (Fig 4). HO-1was previously reported
to be overexpressed when ¢broblasts were exposed to UVA, and
HO-1 induction is considered as part of an adaptive response to
oxidative stress (Vile et al, 1994). In keratinocytes, however, HO-1
was shown to be barely expressed (Applegate et al, 1995). Similar
behavior was observed in our experiments. In ¢broblasts HO-1
induction reached a peak 4 h post treatment, and decreased 24 h
after. As expected, no signi¢cant HO-1 expression could be
detected in keratinocytes (not shown).
Stimulation of p53 pathway by lome£oxacin plus UVA
exposure When DNA is damaged, speci¢c signaling pathways
can be stimulated in response to genotoxic stress in order to
maintain homeostasis. Among them, the tumor suppressor gene
Figure1. Photocytotoxic impact of lome£ox-
acin on ¢broblasts, keratinocytes, and melano-
cytes assessed by the decrease of cell viability
24 h post treatment (MTT colorimetric assay).
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p53 plays a major role in protecting genome integrity (Hall and
Lane, 1997; Levine, 1997).
Figure 5 con¢rms that in cells treated with lome£oxacin and
exposed to UVA, p53 was stabilized as detected by western
blot analysis and densitometry of the autoradiography. p53
accumulated di¡erently in amount and kinetics according to cell
type. Interestingly, in keratinocytes, p53 stabilization was the
highest 24 h post exposure for the three concentrations studied,
whereas in ¢broblasts it was relatively similar for 424 h post
treatment for 10 mM but it did not occur for 1 mM. This
di¡erence in kinetics and intensity could re£ect the higher level
of CPD in genomic DNA of keratinocytes as it is well established
that the delay for CPD repair can exceed 24 h in skin (Young
et al, 1996). Moreover, in melanocytes, p53 never accumulated at
a signi¢cant rate, even at 10 mM lome£oxacin. This result is
consistent with the low genotoxic e¡ect in pigment cells
observed above using the comet assay.
Figure 5 shows that the p21 protein accumulated as well 8 h
and 24 h post exposure in keratinocytes and ¢broblasts,
suggesting that p53 was controlling the cell cycle in response to
lome£oxacin-induced DNA damage. In keratinocytes, however, a
decrease in p21 accumulation was observed 24 h after exposure to
5 mM and more clearly to 10 mM lome£oxacin, suggesting that
induction of the apoptotic pathway replaced cell cycle arrest in
such stress conditions.
MDM2 gene contains a p53 binding site and its expression
increases in the presence of wild-type p53 (see Lane and
Hall, 1997, for a review). It is thus an interesting marker to
Figure 2. DNA breakage induced by
lome£oxacin in nuclei of cells exposed
to UVA. (a) Typical comets observed im-
mediately after exposure to UVA (15 min)
of cells treated by lome£oxacin (20 mM).
The ¢gure shows aspects of nuclei in unex-
posed control (identical for all cell types and
for UVA alone), ¢broblasts, keratinocytes,
and melanocytes. (b) Quanti¢cation by im-
age analysis (mean tail moments of 50 nu-
clei, bars represent standard deviation) of
comets observed after exposure to UVA (15
min) of skin cells treated with increasing
lome£oxacin concentrations.
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Figure 3. Detection of thymine dimers by
dot-blot analysis in genomic DNA isolated
from ¢broblasts (upper part) or from keratino-
cytes (lower part) immediately after treatment
by lome£oxacin (50 and 100 mM) and expo-
sure to UVA (30 min). The amounts of DNA
spotted on the membrane were 1.4, 1.6, 1.8, and
2 mg.
Figure 4. Expression of HO-1 gene in ¢bro-
blasts treated by lome£oxacin and exposed to
UVA (30 min) assessed at 4 h and 24 h post
treatment. Quanti¢cation (mean value from
two independent experiments, bars represent
standard deviation) was standardized with
GAPDH expression measured simultaneously.
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demonstrate the activation of the p53 pathway. Figure 6 shows
that in ¢broblasts and in keratinocytes MDM2 was induced 24 h
post treatment whereas no signi¢cant expression was observed
after 4 h. This result strongly suggests that lome£oxacin exposed
to UVA not only stabilized p53 protein but also led to activation
of the p53 pathway. Figure 7 con¢rms this hypothesis, taking
GADD45 expression as another endpoint to assess p53
activation. GADD45 is generally reported to be trans-activated
by p53 in response to DNA damage induction. In this study, the
induction was stronger in keratinocytes than in ¢broblasts and, in
both cases, was detectable from 4 h to 24 h post exposure
although less intensely in ¢broblasts after 24 h.
Exposure to lome£oxacin plus UVA can trigger apoptosis in
human keratinocytes Apoptosis can be an ultimate response
to various stresses. It involves a large number of biochemical
processes such as caspase activation or Fas/Fas-L interaction.
Caspases are proteins that play an essential role during
apoptotic cell death: once activated, they cleave various essential
cellular components. Caspase-3 has a central role in this process
and is considered as the main activator of apoptotic DNA
fragmentation. Its involvement in UV-induced apoptosis has
been previously described (see Cohen, 1997, for a review).
FAS-L expression was previously reported to participate in
DNA-damage-induced apoptosis and is induced in response to
di¡erent kinds of stress (Leverkus et al, 1997; Pinkoski and
Green, 1999). Moreover, it was recently published that, in skin,
sunburn cell formation required Fas and Fas-L interaction (Hill
et al, 1999). Using both biologic markers, we observed that
keratinocytes (but not ¢broblasts) underwent apoptosis after
UVA exposure in the presence of lome£oxacin. Figure 8 shows
that caspase-3 was activated from 8 h post exposure (peak of
activation) up to 24 h using 10 mM lome£oxacin plus UVA. It
can be noticed that a slight activation could even be detected
with 5 mM lome£oxacin. In Fig 9, FAS-L gene induction
con¢rmed the stimulation of apoptosis in keratinocytes and this
induction occurred as early as 8 h post treatment as observed with
caspase-3. Here again, no signi¢cant changes could be observed
in ¢broblasts even with increasing lome£oxacin concentration
up to 20 mM (not shown).
Exposure to lome£oxacin plus UVA can stimulate
pigmentation in human melanocytes Melanogenesis is
considered as a defense mechanism against various stresses and it
was proposed that DNA damage can trigger pigmentation (Eller
et al, 1996). Figure 10 shows that exposure to lome£oxacin plus
UVA clearly changed tyrosinase status within melanocytes from
two Caucasian donors having di¡erent basal tyrosinase activity.
Five days after treatment with lome£oxacin (up to 10 mM),
stimulation of dopa-oxidase activity of tyrosinase was observed.
In parallel, a decrease in cell proliferation assessed by cell
counting was evidenced, probably as a consequence of growth
arrest as no cell death was observed (see Fig 1). This ¢nding is
consistent with the assumption that pigmentation can be a
peculiar defense mechanism of melanocytes against phototoxic
processes.
DISCUSSION
This study shows that lome£oxacin could induce DNA breaks,
produce pyrimidine dimers via photosensitization, and lead to
cell growth arrest or cell death. In addition, striking di¡erences
were observed depending on cell type for each endpoint re-
corded. Keratinocytes were the most sensitive cells, melanocytes
the most resistant ones, and ¢broblasts showed intermediate sen-
sitivity (seeTable I).
As DNA damage was assessed immediately after treatment,
these results cannot be explained by di¡erences in DNA repair
kinetics, at least if one considers the nucleotide excision repair
pathway. Repair of pyrimidine dimers would take more than 24
h to be completed (Young et al, 1996); it is thus unlikely that sig-
ni¢cant di¡erences would occur during the 30 min UVA expo-
sure. Moreover, neonatal cells were used here, which excluded a
potential relationship with repair e⁄cacy as a function of age
of the donor (Goukassian et al, 2000), even if some individual
Figure 5. P53 status in cells treated by lome£axacin and exposed to
UVA. (a) Western blot detection of p53 and p21 proteins in ¢broblasts,
keratinocytes, and melanocytes treated with lome£oxacin and exposed to
UVA (30 min). Proteins were extracted from nuclei 4 h, 8 h (except for
melanocytes), and 24 h post exposure. (b) Densitometric analysis of p53
and p21 bands scanned from the western blot shown in (a).Values represent
the ratio between assays and untreated control for each cell type.
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Figure 6. Expression of the MDM2 gene in ¢broblasts and keratinocytes 24 h after treatment with lome£oxacin and UVA (30 min). Quanti¢cation (mean
value from two independent experiments, bars represent standard deviation) was standardized with GAPDH expression measured simultaneously.
Figure 7. Expression of GADD45 gene in ¢broblasts and keratinocytes 4 h and 24 h after treatment with lome£oxacin and UVA (30 min). Quanti¢cation
(mean value from two independent experiments, bars represent standard deviation) was standardized with GAPDH expression measured simultaneously.
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di¡erences may exist (Bykov et al, 1999). It appears more likely that
lome£oxacin uptake, bioavailability within cells (in particular in
the nucleus), or potential metabolic activation (or inactivation)
may play a role. In fact, it was recently published that microsomal
metabolism of cipro£oxacin (a £uoroquinolone comparable in
structure to lome£oxacin) generated free radicals (Gˇrbay et al,
2001). Lome£oxacin mainly accumulates in lysosomes (Ouedrao-
go et al, 1999), but the fraction that escapes these organelles and
that is capable of inducing damage elsewhere is still unknown. It
would be interesting to study ‘‘dark’’ e¡ects of lome£oxacin dur-
ing longer preincubation times or the e¡ects of exogenous meta-
bolic activation.
This study also showed that endogenous cellular defense
against photosensitized lome£oxacin-induced oxidative stress var-
ied from one cell type to another. The most obvious di¡erence
was associated with the presence of melanin. Melanin is consid-
ered as a double-edged sword because, on one hand, it can be
activated by light and produce reactive species but, on the other
hand, it behaves as a scavenger of free radicals (Hill et al, 1997).
Moreover melanin can bind various organic molecules (Mars
and Larsson, 1999) including £uoroquinolones (Fukuda et al,
2000). The fact that melanocytes appeared more resistant in our
experiments is therefore not really surprising. Once bound to
melanin, lome£oxacin is no longer available (or less available)
for interacting with DNA in the nucleus, but one cannot exclude
that this storage could ¢nally be deleterious, if the drug is re-
leased from the pigment as previously reported for the £uoroqui-
nolone spar£oxacin (Hamanaka et al, 1999). Melanocytes were
sensitive to the stress produced by lome£oxacin exposed to
UVA, however, as melanogenesis was stimulated. Tyrosinase
activity (evaluated in our experiments by dopa-oxidase activity),
which controls melanogenesis, can be modulated by post-transla-
tional modi¢cations of the enzyme in response to exogenous
genotoxic stimuli. It was recently suggested that activation of
melanogenesis could be controlled by p53 (Nylander et al, 2000;
Khlgatian et al, 2002). But tyrosinase is also in£uenced by the re-
dox status within cells and O2 was shown to be a better substrate
than O2 (Wood and Schallreuter, 1991; Schallreuter et al, 1994).
Production of ROS by photosensitized lome£oxacin could thus
have a direct impact on melanogenesis.
The striking di¡erence observed between keratinocytes and
¢broblasts is a bit more unexpected. First, it was reported
elsewhere that the same UVB dose induced less CPD in keratino-
cytes than in ¢broblasts (Otto et al, 1999). Opposite results are ob-
served here, but mechanisms of direct CPD induction by UVand
CPD photosensitization by lome£oxacin might be di¡erent. A
tight interaction between the drug (or its photoproducts) and
DNA is necessary in order to ensure the transfer of the photonic
energy.Why such an interaction could be facilitated in keratino-
cytes remains to be elucidated.
DNA strand breakage detected by the comet assay immedi-
ately after exposure was higher in keratinocytes than in ¢bro-
blasts. Assuming that most of this breakage was due to the
cleavage of the DNA phosphodiester backbone by ROS, one
might question the antioxidant status in each cell type. Published
data show that the epidermis (or keratinocytes) has better antiox-
idant defenses than dermis (or ¢broblasts). In fact, glutathione,
antioxidant enzymes such as superoxide dismutase, or constitutive
heme-oxygenase-2 contents are higher in epidermal cells (Shindo
et al, 1994; Applegate et al, 1995; Niggli and Applegate, 1997; Leccia
et al, 1998) although glutathione peroxidase is sometimes present
at higher concentrations in ¢broblasts from di¡erent human
donors (Moysan et al, 1995). Thus, the endogenous level of antiox-
idants cannot explain our results.
One could also think that repair of DNA oxidative lesions oc-
curred faster in keratinocytes resulting in a large induction of in-
cisions in DNA (or of alkaline-sensitive sites such as abasic sites)
in a short time. It is well established that most oxidative damage
(such as 8-oxo-guanine) is processed by the base excision repair
Figure 8. Activation of caspase-3 in keratinocytes treated with lome£oxa-
cin and exposed to UVA (30 min). Proteins were extracted from cells 8 h
and 24 h post exposure and assessed for caspase-3 activity using a colori-
metric assay as described in Materials and Methods.
Figure 9. Expression of the FAS-L gene in ker-
atinocytes treated with lome£oxacin and ex-
posed to UVA (30 min) assessed 8 h and 24 h
post exposure. Quanti¢cation (mean value from
two independent experiments, bars represent
standard deviation) was standardized with
GAPDH expression measured simultaneously.
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pathway, which is completed faster than nucleotide excision re-
pair. It is thus likely that DNA incisions start to be induced by
repair enzymes during UVA exposure. In line with this, comets
observed immediately after treatment were more intense in kera-
tinocytes. But we also noticed that p53 accumulation and
GADD45 expression lasted much longer in keratinocytes than in
¢broblasts. Oxidative DNA photolesions induced by UVA-ex-
posed lome£oxacin were probably shortly repaired whereas bulky
lesions, such as CPD, were repaired much more slowly. It is thus
possible that a higher induction of both types of DNA lesion
combined with di¡erences in repair kinetics could in£uence the
behavior of keratinocytes in our experiments.
Finally, the marked photocytotoxicity of lome£oxacin in
keratinocytes could be explained by the ability of these cells to
undergo apoptosis as shown by caspase-3 activation and FAS-L
induction. In fact, p53 was reported to trigger apoptosis in highly
damaged cells, depending, however, on a variety of factors such as
biochemical environmental conditions and cell type (Polyak et al,
1997). As it was observed in this study that the p53 pathway was
triggered, p53-dependent stimulation of apoptosis might be sti-
mulated by UVA-photosensitized lome£oxacin. The induction
of CPD could also greatly contribute to apoptosis, as it does in
epidermis when sunburn cells are formed after UVB exposure.
In fact, the formation of sunburn cells (apoptotic keratinocytes)
requires Fas and Fas-L interaction: Fas and Fas-L may serve as ex-
ternal pro-apoptotic sensors of DNA-damage-mediated cellular
proof-reading (Hill et al, 1999) and DNA damaging agents have
been shown to induce expression of FAS-L via the activation of
AP1, a transcription factor for various stress genes. Moreover, it
was reported that photosensitized lome£oxacin could also induce
a marked delayed destabilizing e¡ect on mitochondrial mem-
brane (Ouedraogo et al, 2000) and it is established that the altera-
tion of mitochondrial membrane is an important step in
apoptosis development (see Kroemer and Reed, 2000, for a re-
view). The activation of caspase-3 followed by keratinocyte cell
death could result from this process. Interestingly, lome£oxacin
was reported to trigger apoptosis in retinal cells of albino
BALB/c mice but not in pigmented DBA/2 mice under UVA ex-
posure (Shimoda and Kato, 1999). In addition to the possible pro-
tective role of melanin previously discussed, these published data
also underline that apoptosis could occur in response to lome£ox-
acin phototoxicity.
In addition to this information about molecular processes, our
results also raise the question of the biologic endpoints used for
phototoxicity assessment. Reliable evaluation of photocytotoxi-
city is needed for early detection of the photodamaging potential
of photo-unstable compounds. Neutral Red uptake using 3T3 ¢-
broblasts was recently validated as an alternative to animal testing
in this regard (Spielmann et al, 1998). Our data suggest that cell
death cannot be the sole endpoint to assess phototoxicity, how-
ever, as signi¢cant amounts of DNA lesions (enough to activate
stress genes) could be induced at subphotocytotoxic doses. These
results also stress the fact that photosensitivity can vary from one
cell type to another. For instance, normal human keratinocytes,
which are the ¢rst and prevalent targets of xenobiotics in skin,
may respond di¡erently compared to ¢broblasts (normal human
cells or 3T3 cell line) in culture.
Finally, the choice of suitable references for phototoxicity as-
sessment is an important issue. 8-Methoxy-psoralen (8-MOP)
can be regarded as a very suitable molecule because therapeutic
use gave rise to numerous clinical studies about its phototoxicity
and its possible implication in photocarcinogenesis (Gasparro
et al, 1998; Lindel˛f et al, 1999). According to its chemical structure,
however, 8-MOP interacts in a very peculiar way with DNA. It
induces photolesions such as bulky mono-adducts and interstrand
crosslinks that have a strong genotoxic impact. As a consequence,
the molecular responses due to lesions such as strand breaks or
oxidative damage could not be studied using 8-MOP. 8-MOP
can thus hardly be the only reference when one wants to assess
the phototoxicologic potential of various chemicals. In this
respect, lome£oxacin appears to provide another interesting
and complementary candidate: it also increases the risk of photo-
carcinogenesis in mice (Klecak et al, 1997), but it induces DNA
damage of a type that is more frequently encountered in photo-
toxicity. Considering the increasing pattern of our understanding
of the mechanisms involved in its photoreactivity/phototoxicity,
lome£oxacin might be a convenient reference, together with 8-
MOP, to assess the phototoxic potential of new drugs.
Table I. Summary of responses observed in the three human
cell types photosensitized by lome£oxacin and UVA
Keratinocytes Fibroblasts Melanocytes
MTTassay High photo-
cytotoxicity
Low photo-
cytotoxicity
No photo-
cytotoxicity
up to 25 mM
Comet assay þ þ þ þ þ þ
CPD formation þ þ þ ND
p53 accumulation þ þ (particularly
at 24 h)
þ 0
p21 accumulation þ (0 at high
concentrations
at 24 h)
þ 0
MDM2 induction þ þ þ þ ND
GADD45 induction þ þ (4 h
and 24 h)
þ (4 h) ND
HO-1 induction 0 þ (4 h) ND
FAS-L induction þ 0 ND
Caspase-3 activation þ (8 h) 0 ND
Tyrosinase activation ND ND þ
ND, not done.
þ to þ þ þ corresponds to increasing responses.
Figure10. Impact of lome£oxacin and UVA (30 min) on cell growth and
dopa-oxidase activity of endogenous tyrosinase in melanocytes from two
Caucasian donors 5 d post exposure.
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